Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing

Recent advances in lung cancer treatment are emerging from new immunotherapies that target T-cell inhibitory receptors, such as programmed cell death-1 (PD-1). However, responses to anti-PD-1 antibodies as single agents are observed in fewer than 20% of non-small-cell lung cancer (NSCLC) patients, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leclerc, Marine, Mezquita, Laura, Guillebot De Nerville, Guillaume, Tihy, Isabelle, Malenica, Ines, Chouaib, Salem, Mami-Chouaib, Fathia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616108/
https://www.ncbi.nlm.nih.gov/pubmed/31333652
http://dx.doi.org/10.3389/fimmu.2019.01505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616108/
https://www.ncbi.nlm.nih.gov/pubmed/31333652
http://dx.doi.org/10.3389/fimmu.2019.01505

Ejemplares similares